12:00 AM
Dec 17, 2012
 |  BC Week In Review  |  Financial News  |  Completed Offerings

Arrowhead completes follow-on

Arrowhead Research Corp. (NASDAQ:ARWR), Pasadena, Calif.
Business: Drug delivery
Date completed: 12/7/12
Type: Follow-on

Read the full 54 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >